1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4:

Analysis of refractures within 1 year

Percentage of Patients Having a Second Treatment Session Within 1 y of Initial ProcedurePercentage of Refractured Patients Having a Third Treatment Session Within 1 y of Initial ProcedureAverage Available Cement Volumes for Patients Refracuring Within 1 y of Initial Procedure (cc)Average Time Between Treatment Sessions for Refracturing Patients Within 1 y of Initial Procedures
No. of Patients Having Initial ProcedureNo. Refractured (2nd Procedure)% RefracturingNo. Refractured (2nd Procedure)No. Refractured (3rd Procedure)% of Refractured Patients Having 3rd ProcedureΔt Between 1st and 2nd procedure wkΔt Between 2nd and 3rd procedure wk
Primary osteoporosis3507220.6722331.9%5.18 ± 2.5811.312
Steroid-induced osteoporosis371437.814642.9%5.97 ± 3.027.9310.8
Total3878622.2862933.7%
Relative risk1.841.34
P value.0163.3094
  • * Chi-squared analysis.

  • Fisher exact test.